CDP Venture Capital's Biotechnology Portfolio

Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products

Developing analytical systems to characterize next-generation cancer immunotherapy

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Digital biotech startup offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for rare diseases

Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

GI develops super-resolution optical microscopes, empowering researchers to explore the microscopic world with unprecedented detail.

Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology.

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

MOGU is a European company, based in Italy, developing a range of mycelium-based technologies.

Morphocell Technologies is a regenerative medicine company.

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.